Paul Breillat

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.

Journal: JAMA dermatology

Published: November 19, 2025

Cutaneous Vasculitis in Primary Sjögren Disease.

Cutaneous Vasculitis in Primary Sjögren Disease.

Journal: JAMA dermatology

Published: September 12, 2025

Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Journal: Blood

Published: September 09, 2025

Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Journal: Blood

Published: September 09, 2025

Sickle Cell Diastolic Cardiomyopathy and Mortality Risk: A Novel Echocardiographic Framework for Prognostic Stratification.

Sickle Cell Diastolic Cardiomyopathy and Mortality Risk: A Novel Echocardiographic Framework for Prognostic Stratification.

Journal: American journal of hematology

Published: June 03, 2025

Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Journal: Blood

Published: December 23, 2024

Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Journal: Lupus

Published: January 20, 2023

VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

Journal: Nature communications

Published: October 23, 2022

Characteristics of cutaneous lupus erythematosus in Black patients, association with systemic lupus and response to treatment: A retrospective cohort study of 141 patients.

Characteristics of cutaneous lupus erythematosus in Black patients, association with systemic lupus and response to treatment: A retrospective cohort study of 141 patients.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 23, 2022

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Journal: Rheumatology (Oxford, England)

Published: May 17, 2022

Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.

Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.

Journal: Rheumatology (Oxford, England)

Published: April 14, 2022

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

Journal: Annals of the rheumatic diseases

Published: March 26, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026